Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25171633 | 0.81 | DGAT1 (0.37) | DGAT1NPC1 | |
| SCHEMBL28496046 | 0.81 | DGAT1 (0.38) | DGAT1NPC1 | |
| SCHEMBL10200583 | 0.80 | DGAT1 (0.34) | DGAT1NPC1 | |
| SCHEMBL28912548 | 0.80 | DGAT1 (0.34) | DGAT1NPC1 | |
| SCHEMBL30877301 | 0.80 | DGAT1 (0.34) | DGAT1NPC1 | |
| SCHEMBL28624418 | 0.80 | DGAT1 (0.37) | DGAT1NPC1 | |
| SCHEMBL3262382 | 0.79 | DGAT1 (0.34) | DGAT1NPC1 | |
| SCHEMBL28627973 | 0.78 | DGAT1 (0.33) | DGAT1NPC1 | |
| SCHEMBL29862373 | 0.76 | DGAT1 (0.33) | DGAT1 | |
| SCHEMBL3526518 | 0.76 | NPC1 (0.37) | DGAT1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829547-A | Factor XIIa inhibitors | 卡尔维斯塔制药有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-113620956-B | Transforming growth factor receptor antagonist, preparation method and application thereof | 赛诺哈勃药业（成都）有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-116171280-A | Casein kinase 1 delta modulators | 詹森药业有限公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-115427404-A | Collagen 1 translation inhibitors and methods of use thereof | 艾尼莫生物科技公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-109790158-B | Heterocyclic compounds as JAK inhibitors, salts of the compounds and therapeutic use thereof | 苏州隆博泰药业有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-110248939-B | Tyrosine amide derivatives as RHO-kinase inhibitors | 奇斯药制品公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-113620956-A | Transforming growth factor receptor antagonist, preparation method and application thereof | 成都倍特药业股份有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-112823005-A | Pyrrolopyrimidine ITK inhibitors | 阿克拉瑞斯治疗股份有限公司 | 2021-05-18 | — | — | CN | disclosed |
| EP-2857400-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2015-04-08 | — | — | EP | disclosed |